Live from the NIH registry
Studies recruiting near Thousand Oaks right now
Top 25 of 678 recruiting studies, sorted by proximity — each links to its official registry page
Lung-MAP: A Master Screening Protocol for Previously-Treated Non-Small Cell Lung Cancer
Previously Treated Non-Small Cell Lung Cancer
Phase 2, Phase 3
Interventional 10,000 participants sought
Kaiser Permanente-Woodland Hills — Woodland Hills, California (15.5 mi)
· Sponsor: SWOG Cancer Research Network
Housing Transitions QUERI
Homelessness
Phase 1
Interventional 153 participants sought
VA Greater Los Angeles Healthcare System, West Los Angeles, CA — West Los Angeles, California (27.4 mi)
· Sponsor: VA Office of Research and Development
Phase 3 Study of RLY-2608 + Fulvestrant vs Capivasertib + Fulvestrant as Treatment for Locally Advanced or Metastatic PIK3CA-mutant HR+/HER2- Breast Cancer
PIK3CA Mutation, HER2- Negative Breast Cancer
Phase 3
Interventional 540 participants sought
Beverly Hills Cancer Center — Beverly Hills, California (28.4 mi)
· Sponsor: Relay Therapeutics, Inc.
DESTINY-Endometrial01: A Phase III Study of Trastuzumab Deruxtecan Plus Rilvegostomig or Pembrolizumab as First-Line Treatment of HER2-Expressing (IHC 3+/2+), Mismatch Repair Proficient (pMMR) Endometrial Cancer
Endometrial Cancer
Phase 3
Interventional 600 participants sought
Research Site — Sylmar, California (25.6 mi)
· Sponsor: AstraZeneca
A Study to Determine the Efficacy and Safety of Finerenone and SGLT2i in Combination in Hospitalized Patients With Heart Failure (CONFIRMATION-HF)
Heart Failure
Phase 3
Interventional 1,500 participants sought
CON-10109, Van Nuys, CA — Van Nuys, California (24.4 mi)
· Sponsor: Colorado Prevention Center
E-Mindfulness Approaches for Living After Breast Cancer
Breast Cancer, Depression
Phase 3
Interventional 402 participants sought
Kaiser Permanente-Woodland Hills — Woodland Hills, California (15.5 mi)
· Sponsor: NRG Oncology
Inclisiran Versus Placebo for the Prevention of Major Adverse Cardiovascular and Limb Events in Patients Undergoing Percutaneous Coronary Intervention or Peripheral Endovascular Intervention
Percutaneous Coronary Intervention, Peripheral Endovascular Intervention
Phase 4
Interventional 6,000 participants sought
Interventional Cardiology Medical Group — West Hills, California (13.2 mi)
· Sponsor: Duke University
A Study to Find a Suitable Dose of ASP5834 in Adults With Solid Tumors
Solid Tumor, Non-Small-Cell Lung Cancer
Phase 1
Interventional 364 participants sought
UCLA Santa Monica Hematology Oncology — Santa Monica, California (25.0 mi)
· Sponsor: Astellas Pharma Inc
Study of Efficacy and Safety of Iptacopan in Participants With IC-MPGN
IC-MPGN
Phase 3
Interventional 106 participants sought
Olive View UCLA Medical Center — Sylmar, California (25.6 mi)
· Sponsor: Novartis Pharmaceuticals
uTRACT Jelmyto Registry: A Registry of Patients With Upper Tract Urothelial Cancer (UTUC) Treated With Jelmyto
Urothelial Carcinoma, Urothelial Carcinoma Recurrent
N/A
Observational 400 participants sought
Providence St. Johns Health Center — Santa Monica, California (25.0 mi)
· Sponsor: UroGen Pharma Ltd.
A Study Assessing Long-Term Safety and Effectiveness in Treatment Management of Atrial Fibrillation With VARIPULSE Catheter System
Atrial Fibrillation
N/A
Interventional 276 participants sought
Community Memorial Hospital — Ventura, California (24.6 mi)
· Sponsor: Biosense Webster, Inc.
A Phase 2, Baseline-Controlled Study Evaluating the Safety and Efficacy of PTX-022 (Sirolimus) Topical Gel 3.9% in the Treatment of Angiokeratomas (LOTU)
Angiokeratomas
Phase 2
Interventional 15 participants sought
Unified Health — Sherman Oaks, California (24.5 mi)
· Sponsor: Palvella Therapeutics, Inc.
Phase 3 Extension Study to Evaluate Long-term Safety of Ianalumab in Participants With Systemic Lupus Erythematosus (SIRIUS-SLE Extension).
Systemic Lupus Erythematosus
Phase 3
Interventional 550 participants sought
Millennium Clinical Trials — Westlake Village, California (5.1 mi)
· Sponsor: Novartis Pharmaceuticals
Low PSMA SUV Boost (LPS-Boost): Intensified 177Lu-PSMA-617 Treatment for Patients With Metastatic Castrate-Resistant Prostate Cancer With Low PSMA Expressing Disease
Metastatic Castration-Resistant Prostate Carcinoma, Stage IVB Prostate Cancer AJCC v8
Phase 2
Interventional 51 participants sought
Olive View-University of California Los Angeles Medical Center — Sylmar, California (25.6 mi)
· Sponsor: University of Washington
This Study Will Explore Whether a Combination of the Investigational Drug Mevrometostat (PF-06821497) and Enzalutamide Will Work Better Than Taking Enzalutamide Alone in Participants With mCSPC Who Are ARPI naïve.
Metastatic Castration Sensitive Prostate Cancer (mCSPC), Hormone Sensitive Prostate Cancer
Phase 3
Interventional 1,000 participants sought
UCLA Hematology/Oncology - Westlake — Westlake Village, California (5.1 mi)
· Sponsor: Pfizer
Study to Evaluate the Maximal Use of Ruxolitinib Cream in Adult and Adolescent Participants With Hidradenitis Suppurativa
Hidradenitis Suppurativa
Phase 1
Interventional 24 participants sought
Clinical Trials Research Institute — Thousand Oaks, California (2.6 mi)
· Sponsor: Incyte Corporation
Clinical Study of the inQB8 TTVR System (The MonarQ Study)
Tricuspid Valve Regurgitation
N/A
Interventional 50 participants sought
Los Robles Hosptial and Medical Center — Thousand Oaks, California (2.6 mi)
· Sponsor: inQB8 Medical Technologies, LLC
A Study to Learn About the Study Medicine Called Rimegepant in Women When Used for Intermittent Prevention of Menstrual Migraine
Menstrual Migraine
Phase 3
Interventional 723 participants sought
Hope Clinical Research, Inc. — Canoga Park, California (15.9 mi)
· Sponsor: Pfizer
A Study of Dotinurad Versus Allopurinol in Participants With Gout
Gout
Phase 3
Interventional 500 participants sought
Cohen Medical Centers — Thousand Oaks, California (2.6 mi)
· Sponsor: Crystalys Therapeutics
The Effect of Kinisoquin™ on Thromboembolic Events in Patients With Metastatic or Locally Advanced Pancreatic Cancer
Venous Thromboembolism, Metastatic Pancreatic Cancer
Phase 3
Interventional 480 participants sought
Ventura Clinical Trials — Ventura, California (24.6 mi)
· Sponsor: Quercis Pharma AG
A Study of Modified Release RTN-001 In Patients With Uncontrolled Hypertension
Uncontrolled Hypertension
Phase 2
Interventional 280 participants sought
Retension Clinical Site — West Hills, California (13.2 mi)
· Sponsor: Retension Pharmaceuticals. Inc.
A Phase 3 Efficacy and Safety Study of HBS-301 in Participants With Idiopathic Hypersomnia (IH)
Idiopathic Hypersomnia
Phase 3
Interventional 248 participants sought
Santa Monica Clinical Trials — Santa Monica, California (25.0 mi)
· Sponsor: Harmony Biosciences Management, Inc.
An Open Label Extension (OLE) Study (Following Completion of CTQJ230A12301) to Evaluate Long-term Safety and Tolerability of Pelacarsen (TQJ230)
Cardiovascular Disease and Lipoprotein(a)
Phase 3
Interventional 5,700 participants sought
Interv Cardiology Med Grp — West Hills, California (13.2 mi)
· Sponsor: Novartis Pharmaceuticals
Study of VOY-101 in Patients With Advanced Non-Neovascular Age-Related Macular Degeneration
Age-Related Macular Degeneration, Geographic Atrophy
Phase 1, Phase 2
Interventional 60 participants sought
The Retina Partners — Encino, California (21.5 mi)
· Sponsor: Perceive Biotherapeutics, Inc.
Docetaxel to Androgen Receptor Pathway Inhibitors in Patients With Metastatic Castration Sensitive Prostate Cancer and Suboptimal PSA Response
Prostate Cancer (Adenocarcinoma)
Phase 3
Interventional 830 participants sought
Kaiser Permanente-Woodland Hills — Woodland Hills, California (15.5 mi)
· Sponsor: Canadian Cancer Trials Group